Showing results (91-100 of 255) with videos related to
Sort By:
Pageof 26
Frontiers in Immunology|March 7, 2017
Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal TransplantationMiguel López-Botet, Carlos Vilches, Dolores Redondo-Pachón, et al.Ultrasonography (Seoul, Korea)|October 17, 2024
GI-RADS versus O-RADS in the differential diagnosis of adnexal masses: a systematic review and head-to-head meta-analysisMarina Perez, Ainhoa Meseguer, Julio Vara, et al.Plos One|August 12, 2015
HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02Paloma Martín, Isabel Krsnik, Belen Navarro, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptorsJohn A Hammond, Lisbeth A Guethlein, Laurent Abi-Rached, et al.Nucleic Acids Research|November 13, 2010
The IMGT/HLA databaseJames Robinson, Kavita Mistry, Hamish McWilliam, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3Achim K Moesta, Paul J Norman, Makoto Yawata, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2017
Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-CHugo G Hilton, Jeroen H Blokhuis, Lisbeth A Guethlein, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2017
Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA DamageJason L Pugh, Neda Nemat-Gorgani, Paul J Norman, et al.Frontiers in Immunology|June 10, 2021
FCGR Genetic Variation in Two Populations From Ecuador Highlands-Extensive Copy-Number Variation, Distinctive Distribution of Functional Polymorphisms, and a Novel, Locally Common, Chimeric FCGR3B/A (CD16B/A) GeneManuela Moraru, Adriana Perez-Portilla, Karima Al-Akioui Sanz, et al.Diagnostics (Basel, Switzerland)|March 29, 2023
Adenomyosis in Pregnancy-Should It Be Managed in High-Risk Obstetric Units?Rodrigo Orozco, José Carlos Vilches, Ignacio Brunel, et al.Pageof 26